AstraZeneca is to shed 1,400 positions across the UK, Spain, Belgium and Sweden as part of its strategy to improve efficiency across the business.
The company said in a statement that the job losses would come from site closures in Porrino, Spain; Destelbergen, Belgium; and Umea in Sweden. Other jobs will be lost at the company’s facilities in Macclesfield, England and Södertälje in Sweden.
AstraZeneca attributed the losses to the introduction of new manufacturing processes, which have led to efficiency gains across its global supply chain.
Further efficiency gains are expected from the introduction of a regional packing strategy and further investment in its Wuxi plant in China to support the company’s continuing growth in the Asia Pacific markets.
‘These moves are a continuation of AstraZeneca’s programme to improve the organisation’s productivity and efficiency,’ said David Smith, executive vice president operations, AstraZeneca. ‘It moves the supply process closer to the customer, responding to their requirements and improving the security of the product wherever it is bought.’